Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 100

1.

Apolipoprotein E ϵ4 is positively related to spatial performance but unrelated to hippocampal volume in healthy young adults.

Stening E, Persson J, Eriksson E, Wahlund LO, Zetterberg H, Söderlund H.

Behav Brain Res. 2016 Feb 15;299:11-8. doi: 10.1016/j.bbr.2015.11.006. Epub 2015 Nov 12.

PMID:
26581118
2.

Alzheimer Lesions in the Autopsied Brains of People 30 to 50 Years of Age.

Pletnikova O, Rudow GL, Hyde TM, Kleinman JE, Ali SZ, Bharadwaj R, Gangadeen S, Crain BJ, Fowler DR, Rubio AI, Troncoso JC.

Cogn Behav Neurol. 2015 Sep;28(3):144-52. doi: 10.1097/WNN.0000000000000071.

3.

No association between ApoE polymorphism and febrile seizures.

Lavenex P, Lavenex PB, Cachat F, Gehri M, Juvet T.

Neurol Sci. 2016 Jan;37(1):31-6. doi: 10.1007/s10072-015-2351-6. Epub 2015 Aug 2.

PMID:
26233231
4.

Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease.

Kumar NT, Liestøl K, Løberg EM, Reims HM, Mæhlen J.

Virchows Arch. 2015 Aug;467(2):225-35. doi: 10.1007/s00428-015-1772-1. Epub 2015 Apr 22.

PMID:
25898889
5.

Association of gene variants of the renin-angiotensin system with accelerated hippocampal volume loss and cognitive decline in old age.

Zannas AS, McQuoid DR, Payne ME, MacFall JR, Ashley-Koch A, Steffens DC, Potter GG, Taylor WD.

Am J Psychiatry. 2014 Nov 1;171(11):1214-21. doi: 10.1176/appi.ajp.2014.13111543.

6.

Imbalanced hippocampal functional networks associated with remitted geriatric depression and apolipoprotein E ε4 allele in nondemented elderly: a preliminary study.

Shu H, Yuan Y, Xie C, Bai F, You J, Li L, Li SJ, Zhang Z.

J Affect Disord. 2014 Aug;164:5-13. doi: 10.1016/j.jad.2014.03.048. Epub 2014 Apr 2.

7.

Additive genetic effect of APOE and BDNF on hippocampus activity.

Kauppi K, Nilsson LG, Persson J, Nyberg L.

Neuroimage. 2014 Apr 1;89:306-13. doi: 10.1016/j.neuroimage.2013.11.049. Epub 2013 Dec 7.

PMID:
24321557
8.

Polymorphisms in the aldehyde dehydrogenase 2 and dopamine β hydroxylase genes are not associated with Alzheimer's disease.

Komatsu M, Shibata N, Ohnuma T, Kuerban B, Tomson K, Toda A, Tagata Y, Nakada T, Shimazaki H, Arai H.

J Neural Transm (Vienna). 2014 Apr;121(4):427-32. doi: 10.1007/s00702-013-1112-z. Epub 2013 Nov 8.

PMID:
24201835
9.

APOE associated hemispheric asymmetry of entorhinal cortical thickness in aging and Alzheimer's disease.

Donix M, Burggren AC, Scharf M, Marschner K, Suthana NA, Siddarth P, Krupa AK, Jones M, Martin-Harris L, Ercoli LM, Miller KJ, Werner A, von Kummer R, Sauer C, Small GW, Holthoff VA, Bookheimer SY.

Psychiatry Res. 2013 Dec 30;214(3):212-20. doi: 10.1016/j.pscychresns.2013.09.006. Epub 2013 Sep 27.

10.

Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers.

Chételat G, Fouquet M.

Rev Neurol (Paris). 2013 Oct;169(10):729-36. doi: 10.1016/j.neurol.2013.07.025. Epub 2013 Sep 6. Review.

PMID:
24016463
11.

Binding and repressive activities of apolipoprotein E3 and E4 isoforms on the human ApoD promoter.

Levros LC Jr, Labrie M, Charfi C, Rassart E.

Mol Neurobiol. 2013 Dec;48(3):669-80. doi: 10.1007/s12035-013-8456-0. Epub 2013 May 30.

PMID:
23715769
12.

Dissecting the gene dose-effects of the APOE ε4 and ε2 alleles on hippocampal volumes in aging and Alzheimer's disease.

Hostage CA, Roy Choudhury K, Doraiswamy PM, Petrella JR; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2013;8(2):e54483. doi: 10.1371/journal.pone.0054483. Epub 2013 Feb 6.

13.

Proteomic analysis of mice expressing human ApoE demonstrates no differences in global protein solubility between APOE 3 and APOE 4 young mice.

Londono C, DeKroon RM, Mocanu M, Booe J, Winnik WM, Swank A, Osorio C, Hamlett ED, Alzate O.

Electrophoresis. 2012 Dec;33(24):3745-55. doi: 10.1002/elps.201200219.

PMID:
23161654
14.

Alzheimer disease family history impacts resting state functional connectivity.

Wang L, Roe CM, Snyder AZ, Brier MR, Thomas JB, Xiong C, Benzinger TL, Morris JC, Ances BM.

Ann Neurol. 2012 Oct;72(4):571-7. doi: 10.1002/ana.23643.

15.

Associative recognition in mild cognitive impairment: relationship to hippocampal volume and apolipoprotein E.

Troyer AK, Murphy KJ, Anderson ND, Craik FI, Moscovitch M, Maione A, Gao F.

Neuropsychologia. 2012 Dec;50(14):3721-8. doi: 10.1016/j.neuropsychologia.2012.10.018. Epub 2012 Oct 24.

PMID:
23103838
16.

Apolipoprotein e genotype-dependent paradoxical short-term effects of (56)fe irradiation on the brain.

Haley GE, Villasana L, Dayger C, Davis MJ, Raber J.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):793-9. doi: 10.1016/j.ijrobp.2011.12.049. Epub 2012 Mar 6.

17.

Association of the Alzheimer's gene SORL1 with hippocampal volume in young, healthy adults.

Bralten J, Arias-Vásquez A, Makkinje R, Veltman JA, Brunner HG, Fernández G, Rijpkema M, Franke B.

Am J Psychiatry. 2011 Oct;168(10):1083-9. doi: 10.1176/appi.ajp.2011.10101509. Epub 2011 Jul 5.

PMID:
21730226
18.
19.

Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study.

Lu PH, Thompson PM, Leow A, Lee GJ, Lee A, Yanovsky I, Parikshak N, Khoo T, Wu S, Geschwind D, Bartzokis G.

J Alzheimers Dis. 2011;23(3):433-42. doi: 10.3233/JAD-2010-101398.

20.

Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects.

Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang ST, Jack CR Jr, Aisen PS, Petersen RC, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2010 Nov 30;75(22):1976-81. doi: 10.1212/WNL.0b013e3181ffe4d1. Epub 2010 Oct 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk